Page last updated: 2024-08-24

cyclen and Anoxemia

cyclen has been researched along with Anoxemia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhise, A; Bobba, KN; Huynh, PT; Kim, JY; Sarkar, S; Yoo, J	1
Brothers, PJ; Chang, JY; Denny, WA; Lu, GL; Stevenson, RJ; Tercel, M; Ware, DC; Wilson, WR	1

Other Studies

2 other study(ies) available for cyclen and Anoxemia

Article	Year
Development of dansyl based copper(ii) complex to detect hydrogen sulfide in hypoxia. Organic & biomolecular chemistry, 2019, 07-24, Volume: 17, Issue:29 Topics: Animals; Cell Survival; Coordination Complexes; Copper; Cyclams; Dansyl Compounds; Dose-Response Relationship, Drug; Fluorescent Dyes; HeLa Cells; Heterocyclic Compounds; Humans; Hydrogen Sulfide; Hypoxia; Mice; Molecular Structure; Optical Imaging; Structure-Activity Relationship; Tumor Cells, Cultured	2019
N-alkylated cyclen cobalt(III) complexes of 1-(chloromethyl)-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinolin-5-ol DNA alkylating agent as hypoxia-activated prodrugs. Bioorganic & medicinal chemistry, 2011, Aug-15, Volume: 19, Issue:16 Topics: Alkylation; Antineoplastic Agents, Alkylating; Azo Compounds; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cobalt; Cyclams; DNA; Drug Screening Assays, Antitumor; Drug Stability; Female; Heterocyclic Compounds; Humans; Hypoxia; Indoles; Prodrugs; Solubility; Trace Elements	2011

Article

Year

Development of dansyl based copper(ii) complex to detect hydrogen sulfide in hypoxia.

Organic & biomolecular chemistry, 2019, 07-24, Volume: 17, Issue:29

Topics: Animals; Cell Survival; Coordination Complexes; Copper; Cyclams; Dansyl Compounds; Dose-Response Relationship, Drug; Fluorescent Dyes; HeLa Cells; Heterocyclic Compounds; Humans; Hydrogen Sulfide; Hypoxia; Mice; Molecular Structure; Optical Imaging; Structure-Activity Relationship; Tumor Cells, Cultured

2019

N-alkylated cyclen cobalt(III) complexes of 1-(chloromethyl)-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinolin-5-ol DNA alkylating agent as hypoxia-activated prodrugs.

Bioorganic & medicinal chemistry, 2011, Aug-15, Volume: 19, Issue:16

Topics: Alkylation; Antineoplastic Agents, Alkylating; Azo Compounds; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cobalt; Cyclams; DNA; Drug Screening Assays, Antitumor; Drug Stability; Female; Heterocyclic Compounds; Humans; Hypoxia; Indoles; Prodrugs; Solubility; Trace Elements

2011